A new study demonstrates involvement of the inhibitory receptor CTLA-4 in T cell exhaustion during infection with human immunodeficiency virus, adding complexity and diversity to the inhibitory pathways regulating T cell responses during chronic viral infections in humans.
References
Kaufmann, D.E. et al. Nat. Immunol. 8, 1246–1254 (2007).
Blackburn, S.D. & Wherry, E.J. Trends Microbiol. 15, 143–146 (2007).
Greenwald, R.J., Freeman, G.J. & Sharpe, A.H. Annu. Rev. Immunol. 23, 515–548 (2005).
Barber, D.L. et al. Nature 439, 682–687 (2006).
Day, C.L. et al. Nature 443, 350–354 (2006).
Petrovas, C. et al. J. Exp. Med. 203, 2281–2292 (2006).
Trautmann, L. et al. Nat. Med. 12, 1198–1202 (2006).
Steiner, K. et al. Clin. Exp. Immunol. 115, 451–457 (1999).
D'Souza, M. et al. J. Immunol. 179, 1979–1987 (2007).
Korman, A.J., Peggs, K.S. & Allison, J.P. Adv. Immunol. 90, 297–339 (2006).
Hryniewicz, A. et al. Blood 108, 3834–3842 (2006).
Butte, M.J. et al. Immunity 27, 111–122 (2007).
Murphy, K.M., Nelson, C.A. & Sedy, J.R. Nat. Rev. Immunol. 6, 671–681 (2006).
Parry, R.V. et al. Mol. Cell. Biol. 25, 9543–9553 (2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Crawford, A., Wherry, E. Inhibitory receptors: whose side are they on?. Nat Immunol 8, 1201–1203 (2007). https://doi.org/10.1038/ni1107-1201
Issue Date:
DOI: https://doi.org/10.1038/ni1107-1201
- Springer Nature America, Inc.
This article is cited by
-
Cancer immunotherapy–related adverse events: causes and challenges
Supportive Care in Cancer (2020)